CAD 0.02
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 9.43 Million USD | -7.04% |
2022 | 14.46 Million USD | 26.84% |
2021 | 11.4 Million USD | 62.87% |
2020 | 7 Million USD | 51.44% |
2019 | 4.62 Million USD | 46.05% |
2018 | 3.16 Million USD | 798.58% |
2017 | 352.28 Thousand USD | 172.43% |
2016 | 129.31 Thousand USD | -16.18% |
2015 | 154.26 Thousand USD | -50.8% |
2014 | 313.55 Thousand USD | -12.8% |
2013 | 359.56 Thousand USD | -62.53% |
2012 | 959.49 Thousand USD | 105.07% |
2011 | 467.88 Thousand USD | 189.55% |
2010 | 161.59 Thousand USD | 54.15% |
2009 | 104.83 Thousand USD | 5723.94% |
2008 | 1800.00 USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 2.86 Million USD | -10.53% |
2024 Q3 | 3.3 Million USD | 15.24% |
2024 Q1 | 3.2 Million USD | 52.97% |
2023 Q3 | 3.7 Million USD | -8.04% |
2023 FY | 13.44 Million USD | -7.04% |
2023 Q4 | 2.09 Million USD | -43.48% |
2023 Q1 | 3.61 Million USD | 18.71% |
2023 Q2 | 4.02 Million USD | 11.38% |
2022 Q2 | 3.99 Million USD | 25.82% |
2022 FY | 14.46 Million USD | 26.84% |
2022 Q4 | 3.04 Million USD | -28.24% |
2022 Q3 | 4.24 Million USD | 6.31% |
2022 Q1 | 3.17 Million USD | 13.93% |
2021 Q3 | 3.56 Million USD | 39.52% |
2021 Q4 | 2.78 Million USD | -21.84% |
2021 FY | 11.4 Million USD | 62.87% |
2021 Q1 | 2.49 Million USD | 27.14% |
2021 Q2 | 2.55 Million USD | 2.41% |
2020 Q1 | 1.64 Million USD | 1.84% |
2020 FY | 7 Million USD | 51.44% |
2020 Q4 | 1.96 Million USD | 20.43% |
2020 Q3 | 1.62 Million USD | -7.71% |
2020 Q2 | 1.76 Million USD | 7.5% |
2019 Q3 | 626.44 Thousand USD | -67.33% |
2019 Q4 | 1.61 Million USD | 157.47% |
2019 FY | 4.62 Million USD | 46.05% |
2019 Q1 | 466.05 Thousand USD | -35.78% |
2019 Q2 | 1.91 Million USD | 311.49% |
2018 FY | 3.16 Million USD | 798.58% |
2018 Q4 | 725.65 Thousand USD | 37.69% |
2018 Q3 | 527.02 Thousand USD | -65.69% |
2018 Q2 | 1.53 Million USD | 307.77% |
2018 Q1 | 376.71 Thousand USD | 69.71% |
2017 Q2 | 36.14 Thousand USD | 248.45% |
2017 Q1 | 10.37 Thousand USD | -66.44% |
2017 Q4 | 221.98 Thousand USD | 164.93% |
2017 FY | 352.28 Thousand USD | 172.43% |
2017 Q3 | 83.78 Thousand USD | 131.84% |
2016 Q4 | 30.9 Thousand USD | -15.5% |
2016 FY | 129.31 Thousand USD | -16.18% |
2016 Q2 | 31.8 Thousand USD | 5.96% |
2016 Q3 | 36.57 Thousand USD | 14.99% |
2016 Q1 | 30.02 Thousand USD | 2.25% |
2015 Q2 | 43.76 Thousand USD | -0.65% |
2015 Q4 | 29.35 Thousand USD | -20.85% |
2015 FY | 154.26 Thousand USD | -50.8% |
2015 Q1 | 44.05 Thousand USD | 12.24% |
2015 Q3 | 37.09 Thousand USD | -15.25% |
2014 Q3 | 40.96 Thousand USD | -74.86% |
2014 FY | 313.55 Thousand USD | -12.8% |
2014 Q1 | 68.94 Thousand USD | 24.73% |
2014 Q2 | 162.98 Thousand USD | 136.41% |
2014 Q4 | 39.24 Thousand USD | -4.2% |
2013 Q1 | 116.44 Thousand USD | -71.93% |
2013 FY | 359.56 Thousand USD | -62.53% |
2013 Q4 | 55.27 Thousand USD | -42.22% |
2013 Q3 | 95.66 Thousand USD | 3.79% |
2013 Q2 | 92.17 Thousand USD | -20.84% |
2012 FY | 959.49 Thousand USD | 105.07% |
2012 Q3 | 175.19 Thousand USD | 0.61% |
2012 Q2 | 174.13 Thousand USD | -10.82% |
2012 Q1 | 195.27 Thousand USD | -31.96% |
2012 Q4 | 414.89 Thousand USD | 136.82% |
2011 Q1 | 21.24 Thousand USD | -55.22% |
2011 FY | 467.88 Thousand USD | 189.55% |
2011 Q3 | 99.12 Thousand USD | 63.83% |
2011 Q2 | 60.5 Thousand USD | 184.87% |
2011 Q4 | 287.01 Thousand USD | 189.54% |
2010 Q4 | 47.43 Thousand USD | -16.53% |
2010 Q3 | 56.82 Thousand USD | 99.43% |
2010 FY | 161.59 Thousand USD | 54.15% |
2010 Q1 | 28.83 Thousand USD | -18.87% |
2010 Q2 | 28.49 Thousand USD | -1.19% |
2009 Q1 | 34.59 Thousand USD | 0.0% |
2009 Q4 | 35.54 Thousand USD | 25.34% |
2009 Q2 | 26.38 Thousand USD | -23.72% |
2009 Q3 | 28.36 Thousand USD | 7.47% |
2009 FY | 104.83 Thousand USD | 5723.94% |
2008 FY | 1800.00 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | -5686.1% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 19.444% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -11105.833% |
The BC Bud Corporation | 1.28 Million CAD | -635.639% |
BioNxt Solutions Inc. | 6.73 Million CAD | -40.041% |
CordovaCann Corp. | 3.86 Million CAD | -144.41% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | -120.354% |
Captor Capital Corp. | 16.28 Million CAD | 42.035% |
City View Green Holdings Inc. | 705.7 Thousand CAD | -1237.394% |
1CM Inc. | 7.3 Million CAD | -29.149% |
Global Hemp Group Inc. | 551.7 Thousand CAD | -1610.708% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -96.316% |
IM Cannabis Corp. | 22.63 Million CAD | 58.309% |
Lobe Sciences Ltd. | 4.13 Million CAD | -128.403% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | -2306.356% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -15630.188% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | -433.827% |
Ovation Science Inc. | 54.1 Thousand CAD | -17345.68% |
Pharmadrug Inc. | 1.33 Million CAD | -606.968% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | -623.002% |
RAMM Pharma Corp. | 7.48 Million CAD | -26.171% |
RIV Capital Inc. | 21.1 Million CAD | 55.275% |
Revive Therapeutics Ltd. | 3.28 Million CAD | -187.247% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 75.005% |
SLANG Worldwide Inc. | 24.6 Million CAD | 61.643% |
1933 Industries Inc. | 5.12 Million CAD | -84.15% |
Red Light Holland Corp. | 2.02 Million CAD | -367.125% |
Top Strike Resources Corp. | 3.63 Million CAD | -159.878% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 3160.13% |
Adastra Holdings Ltd. | 9.36 Million CAD | -0.828% |